LIFE-study: losartan reduces cardiovascular risk factors more than atenolol
Heinzl, S.
Medizinische Monatsschrift für Pharmazeuten 25(5): 149
2002
ISSN/ISBN: 0342-9601 PMID: 12050919 Document Number: 549626
Document emailed within 1 workday
Related Documents
Liakishev, A.A. 2003: Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol. Results of LIFE study Kardiologiia 43(12): 76Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Rodnick, J.E.; Frischer, A.A. 1984: Cardiovascular risk factors and life changes Journal of Family Practice 19(2): 197-200
Czaja-Miturai, I.; Merecz-Kot, D.; Szymczak, W.; Bortkiewicz, A. 2013: Cardiovascular risk factors and life and occupational stress among policemen Medycyna Pracy 64(3): 335-348
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Burgess, E.D.; Carides, G.W.; Gerth, W.C.; Marentette, M.A.; Chabot, I. 2004: Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective Canadian Journal of Cardiology 20(6): 613-618
Anand, S.S.; Yusuf, S. 1997: Risk factors for cardiovascular disease in Canadians of South Asian and European origin: a pilot study of the Study of Heart Assessment and Risk in Ethnic Groups (SHARE) Clinical and Investigative Medicine 20(4): 204-210
Vrhovski, D.; Mestrić, Z.; Subić, N.; Surina, B.; Kranjcević, S. 1985: Established risk factors and complementary risk factors as additional parameters in evaluating the risk of cardiovascular diseases Lijecnicki Vjesnik 107(11-12): 481-484
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Baumgart, P. 2003: LIFE study proves preventive action. With losartan to do even more against stroke MMW Fortschritte der Medizin 145 Suppl. 1: 7-8
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Vizcaíno, V.M.; Muñoz, A.L.; Aguilar, F.S.; Gutiérrez, R.F.; Sánchez, A.M.; Herráiz, A.C. 2000: Sib-sib correlations of cardiovascular risk factors: the Cuenca study Medicina Clinica 115(10): 370-374
Poljicanin, T.; Dzakula, A.; Milanović, S.M.ć; Sekerija, M.; Ivanković, D.; Vuletić, S. 2012: The changing pattern of cardiovascular risk factors: the CroHort study Collegium Antropologicum 36(Suppl 1): 9-13
Scher, A.I.; Terwindt, G.M.; Picavet, H.S.J.; Verschuren, W.M.M.; Ferrari, M.D.; Launer, L.J. 2005: Cardiovascular risk factors and migraine: the GEM population-based study Neurology 64(4): 614-620
Henriksson, J. 1998: Regular physical activity reduces the risk of cardiovascular disease. Overweight is increasing--we have to exercise! Lakartidningen 95(51-52): 5894-5896
Marín, R.; Fernández-Vega, F.; Escalada, P.; Estevan, J.M.; Barreiro, A.; Alvarez, J. 1993: Cardiovascular risk factors in peripheral arterial disease. a study of 403 cases Revista Clinica Espanola 193(7): 357-362
Patrick, A.L.; Boyd-Patrick, H.A. 1985: Selected cardiovascular risk factors and electrocardiographic findings. A Tobago study West Indian Medical Journal 34(3): 158-166
Laaser, U.; Schütt, A.; Kuschinsky; Gisela; Perbix, W.; Meurer, K.A.; Kaufmann, W. 1976: Cardiovascular risk factors in adolescents. 1st results of the Cologne-study 1975/76 Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1148-1151
Lapierre, R.; Couture, R. 1995: Study of cardiovascular health in Lac-St-Jean-Chibougamau:the prevalence of risk factors L'Union Medicale du Canada 124(2): 22-26
Scheen, A.J. 2015: EMPA-REG OUTCOME: Empagliflozin reduces mortality in patients with type 2 diabetes at high cardiovascular risk Revue Medicale de Liege 70(11): 583-589